Pfenex Inc. | Mutual Funds

Mutual Funds that own Pfenex Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
PRIMECAP Odyssey Aggressive Growth Fund
3,038,100
9.67%
741,000
0.14%
06/30/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
1,430,985
4.55%
561,500
0.33%
06/30/2018
Franklin Small Cap Growth Fund
1,175,631
3.74%
0
0.21%
03/31/2018
Vanguard Total Stock Market Index Fund
682,191
2.17%
0
0%
07/31/2018
Franklin Biotechnology Discovery Fund
532,384
1.69%
0
0.19%
03/31/2018
iShares Russell 2000 ETF
446,865
1.42%
-240
0.01%
09/06/2018
Carnegie Global Health Care Fund
352,153
1.12%
-10,915
1.01%
08/31/2018
Vanguard Extended Market Index Fund
348,733
1.11%
0
0%
07/31/2018
Vanguard Investment Series Plc - US Opportunities Fund
270,300
0.86%
211,000
0.05%
06/30/2018
iShares Russell 2000 Growth ETF
199,143
0.63%
0
0.01%
09/06/2018

About Pfenex

View Profile
Address
10790 Roselle Street
San Diego California 92121
United States
Employees -
Website http://www.pfenex.com
Updated 07/08/2019
Pfênex, Inc. is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. The company was founded on November 19, 2009 and is headquartered in San Diego, CA.